Observational Study to Evaluate the Safety of Levemir® in Diabetes (PREDICTIVE™)

Novo Nordisk logo

Novo Nordisk

Status

Completed

Conditions

Diabetes Mellitus, Type 1
Diabetes
Diabetes Mellitus, Type 2

Treatments

Drug: insulin detemir

Study type

Observational

Funder types

Industry

Identifiers

NCT00706017
NN304-3518

Details and patient eligibility

About

This observational study is conducted in North America. The aim of this observational study is to evaluate the incidence of adverse events while using Levemir® under normal clinical practice conditions.

Enrollment

2,282 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type 1 or 2 diabetes
  • Including newly diagnosed not on insulin or insulin analogue treatment
  • Selection at the discretion of the physician
  • Adult patients with type 1 and 2 diabetes mellitus, and type 1 patients 6 years and older

Exclusion criteria

  • Current treatment with Levemir®
  • Previously enrolled in the study
  • Hypersensitivity to Levemir®

Trial design

2,282 participants in 1 patient group

A
Treatment:
Drug: insulin detemir

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems